Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Is It Too Late to Buy Johnson & Johnson Stock?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Is It Too Late to Buy Johnson & Johnson Stock?

Blue-chip pharmaceutical company Johnson & Johnson (NYSE: Johnson & Johnson) has seen its share of successes over the past 12 months. From developing a COVID-19 vaccine to bolstering a pipeline of

3 Growing Stocks That Recently Raised Their Guidance for 2021
3 Growing Stocks That Recently Raised Their Guidance for 2021

With vaccination rates continuing to climb across the country, the end of the pandemic seems to be in sight. And according a recent IPSOS poll, roughly two-thirds of Americans are optimistic that

Why Does Cathie Wood Like This Healthcare Stock So Much?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Why Does Cathie Wood Like This Healthcare Stock So Much?

ARK Invest founder and CEO Cathie Wood is a fan of companies that hold the potential to be disruptive. In this Motley Fool Live video recorded on April 21, 2021, Motley Fool contributors Keith

Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move
Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move

Last year, so-called stay-at-home stocks took off even as the market dropped due to the COVID-19 pandemic. But many of these same companies have struggled since the beginning of this year. Case in

Why Sarepta's Q1 Results Won't Spark a Rebound for the Beaten-Down BiotechPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Why Sarepta's Q1 Results Won't Spark a Rebound for the Beaten-Down Biotech

Sarepta Therapeutics (NASDAQ: SRPT) has experienced a disastrous year so far, with its shares losing more than half their value. But Wall Street analysts still think that the biotech can turn things

Forget Dogecoin: These Stocks Are Infinitely Smarter Buys: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
Forget Dogecoin: These Stocks Are Infinitely Smarter Buys

For more than a century, the stock market has been the undisputed greatest wealth creator on the planet. Even though certain assets or commodities, such as gold and housing, have had short periods

Why Investors Didn't Like 10x Genomics' Q1 Results
Why Investors Didn't Like 10x Genomics' Q1 Results

10x Genomics (NASDAQ: TXG) has been sizzling hot for much of 2021 so far. It hasn't hurt that Cathie Wood has been busy scooping up shares of the genomics company for her ARK Innovation ETF.

2 Stocks to Invest Your Stimulus Check In
2 Stocks to Invest Your Stimulus Check In

On March 11, President Biden signed the American Rescue Plan into law, making tens of millions of Americans eligible for the COVID-19 pandemic's third round of economic stimulus payments. Over 100

3 Popular Robinhood Penny Stocks Worth Watching
3 Popular Robinhood Penny Stocks Worth Watching

You get what you pay for. That old adage is true with cars, houses, and any other thing you might buy -- including stocks. When something is cheap, there's usually a good reason why.

Of course, a

Vaxart Has 3 Advantages Over Pfizer and ModernaPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Vaxart Has 3 Advantages Over Pfizer and Moderna

Things were looking gloomy for Vaxart (NASDAQ: VXRT) a few months ago. The clinical-stage biotech company reported that its COVID-19 vaccine candidate didn't produce neutralizing antibodies in a

This Warren Buffett Stock Could Be as Risky as Dogecoin:
This Warren Buffett Stock Could Be as Risky as Dogecoin

Warren Buffett didn't take the bait when asked about Bitcoin at the Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) annual shareholder meeting on Saturday. His longtime business partner, Charlie

5 Brand-Name Stocks With 27% to 50% Upside, According to Wall StreetPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/32e7a10f-efd0-424a-861f-2f3e0bb7ce02.png
5 Brand-Name Stocks With 27% to 50% Upside, According to Wall Street

For more than a year, Wall Street has been waving a gigantic green flag for the bulls. After dipping below 2,200 on an intraday basis in March 2020, the benchmark S&P 500 closed above 4,200 for the

These Top 2 Healthcare Companies Are in a Race to RichesPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
These Top 2 Healthcare Companies Are in a Race to Riches

For patients who go through the rigors of daily insulin shots to treat diabetes, the costs and logistics of adhering to a scheduled plan are a lot to keep up with. When not treated properly, low

Claiming Social Security at 65? You May Need to Rethink That
Claiming Social Security at 65? You May Need to Rethink That

Claiming Social Security at 65 may sound like a good plan.

After all, when Franklin D. Roosevelt created the benefits program in 1935, 65 was set as the "standard" retirement age. Any retiree who

3 Things I've Done Right as an Investor
3 Things I've Done Right as an Investor

I'm not the type of person who likes to toot her own horn, and I've certainly made my share of investing mistakes through the years. When stocks tanked last March, for example, I tried to buy

Why Peloton and Zillow Plunged Despite the Dow's Record Close
Why Peloton and Zillow Plunged Despite the Dow's Record Close

The stock market had another topsy-turvy day on Wednesday, with major market benchmarks getting pushed and pulled in both directions at various points. Investors remain concerned about the potential

G1 Therapeutics, Inc. (GTHX) Q1 2021 Earnings Call Transcript
G1 Therapeutics, Inc. (GTHX) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

G1 Therapeutics, Inc. (NASDAQ: GTHX)Q1 2021 Earnings CallMay 5, 2021, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Forrester Research Inc (FORR) Q1 2021 Earnings Call Transcript
Forrester Research Inc (FORR) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

Forrester Research Inc (NASDAQ: FORR)Q1 2021 Earnings CallMay 5, 2021, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Smith Micro Software (SMSI) Q1 2021 Earnings Call TranscriptPhoto, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/12e2798a-1095-4653-8f49-2a7aee633b4e.png
Smith Micro Software (SMSI) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

Smith Micro Software (NASDAQ: SMSI)Q1 2021 Earnings CallMay 05, 2021, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

INmune Bio, Inc. (INMB) Q1 2021 Earnings Call Transcript
INmune Bio, Inc. (INMB) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

INmune Bio, Inc. (NASDAQ: INMB)Q1 2021 Earnings CallMay 05, 2021, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Inseego Corp. (INSG) Q1 2021 Earnings Call Transcript
Inseego Corp. (INSG) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

Inseego Corp. (NASDAQ: INSG)Q1 2021 Earnings CallMay 5, 2021, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Global Blood Therapeutics (GBT) Q1 2021 Earnings Call Transcript
Global Blood Therapeutics (GBT) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

Global Blood Therapeutics (NASDAQ: GBT)Q1 2021 Earnings CallMay 05, 2021, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Zix (ZIXI) Q1 2021 Earnings Call Transcript
Zix (ZIXI) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

Zix (NASDAQ: ZIXI)Q1 2021 Earnings CallMay 05, 2021, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

New Gold (NGD) Q1 2021 Earnings Call Transcript: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
New Gold (NGD) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

New Gold (NYSEMKT: NGD)Q1 2021 Earnings CallMay 05, 2021, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Vericel (VCEL) Q1 2021 Earnings Call Transcript
Vericel (VCEL) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool.

Vericel (NASDAQ: VCEL)Q1 2021 Earnings CallMay 05, 2021, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com